Subarachnoid haemorrhage (SAH) is a type of stroke that is associated with substantial morbidity, requiring neurosurgical and intensive medical management. Recent guidelines for the management of SAH highlight current knowledge and issues that remain to be resolved, and are essential reading for physicians who treat individuals with this condition.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Roger, V. L. et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 123, e18–e209 (2011).
Feigin, V. L., Lawes, C. M., Bennett, D. A., Barker-Collo, S. L. & Parag, V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 8, 355–369 (2009).
Lovelock, C. E., Rinkel, G. J. & Rothwell, P. M. Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology 74, 1494–1501 (2010).
Connolly, E. S. Jr et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 43, 1711–1737 (2012).
Bederson, J. B. et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40, 994–1025 (2009).
Perry, J. J. et al. High risk clinical characteristics for subarachnoid haemorrhage in patients with acute headache: prospective cohort study. BMJ 341, c5204 (2010).
Perry, J. J. et al. Sensitivity of computed tomography performed within six hours of onset of headache for diagnosis of subarachnoid haemorrhage: prospective cohort study. BMJ 343, d4277 (2011).
Furtmuller, R. et al. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a γ-aminobutyric acidA receptor antagonistic effect. J. Pharmacol. Exp. Ther. 301, 168–173 (2002).
Halm, E. A., Lee, C. & Chassin, M. R. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann. Intern. Med. 137, 511–520 (2002).
Molyneux, A. et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial. Lancet 360, 1267–1274 (2002).
Acknowledgements
The author receives research support from the Canadian Institute of Health Research, NIH, Physicians Services Incorporated Foundation, and The Brain Aneurysm Foundation.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
R. L. Macdonald is a consultant for Actelion Pharmaceuticals, and is a stock-holder and patent-holder with Edge Therapeutics.
Rights and permissions
About this article
Cite this article
Macdonald, R. New guidelines for subarachnoid haemorrhage—required reading. Nat Rev Neurol 8, 418–419 (2012). https://doi.org/10.1038/nrneurol.2012.137
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2012.137
